Lee et al. [37] from Korea report a large-scale study specifically investigating the clinical course of HBV infection and the risk of liver dysfunction in Asian patients with IBD receiving anti-tumor necrosis factor-α (anti-TNF-α) therapy. The gene discussed is TNF; the disease is inflammatory bowel disease.